GoHealth Inc Q3 2024 Earnings Revenue Surpasses Estimates at 118. ...
Revenue Reported at 118.3 million for Q3 2024, exceeding analyst estimates of 106.92 million, but down from 132.0 million in the same period last year.Net
Read at gurufocus.com
 |
Pear Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pear Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Pear Therapeutics could also be used in its relative valuation, which is a method of valuing Pear Therapeutics by comparing valuation metrics with similar companies.
Peers
Pear Therapeutics Related Equities
| GOCO | GoHealth | 3.81 | ||||
| AEG | Aegon NV | 3.18 | ||||
| QBEIF | QBE Insurance | 0.00 | ||||
| ORI | Old Republic | 0.03 | ||||
| PLMR | Palomar Holdings | 0.13 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Pear Pink Sheet
If you are still planning to invest in Pear Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pear Therapeutics' history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |